You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic eosinophilic leukaemia (CEL)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs

Not yet recruiting
  • Myeloproliferative Neoplasms (MPNs)
  • Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
  • (no location specified)
Mar 24, 2023

CAR-T Retreatment Trial in Shanghai (axi-cel)

Recruiting
  • CAR-T Retreatment
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Mar 23, 2023

Relapsed/Refractory Large B-Cell Lymphoma Trial in Beijing, Hangzhou (Prizloncabtagene autoleucel)

Recruiting
  • Relapsed/Refractory Large B-Cell Lymphoma
  • Prizloncabtagene autoleucel
  • Beijing, China
  • +1 more
Mar 24, 2023

Multiple Myeloma, Smoldering Multiple Myeloma Trial in Boston (Ciltacabtagene Autoleucel, Cyclophosphamide, Fludarabine

Not yet recruiting
  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • Ciltacabtagene Autoleucel
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 2, 2023

Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma Trial in India (Acalabrutinib capsule)

Active, not recruiting
  • Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma
  • Acalabrutinib capsule
  • Ahmedabad, India
  • +12 more
Feb 2, 2023

French ofQuality of Life Questionnaire for Eosinophilic

Not yet recruiting
  • Eosinophilic Esophagitis
  • Quality of life questionnaire
  • Nice, France
    Hopitaux Pediatriques de Nice Chu-Lenval
Jun 2, 2023

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma Trial in Tianjin (CD19-targeted Chimeric Antigen Receptor(CAR) T Cells)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Diffuse Large B Cell Lymphoma
  • CD19-targeted Chimeric Antigen Receptor(CAR) T Cells
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital
Nov 19, 2023

Eosinophilic Esophagitis Trial in Amsterdam (Intervention)

Recruiting
  • Eosinophilic Esophagitis
  • Intervention
  • Amsterdam, Netherlands
    Amsterdam UMC, location AMC
Feb 15, 2023

Acalabrutinib in Chronic Lymphocytic Leukaemia in United Kingdom

Recruiting
  • Chronic Lymphocytic Leukemia, CLL
  • Aylesbury, United Kingdom
  • +7 more
Jan 12, 2023

Lymphoma, Lymphoma Cns Trial in Boston (Fludarabine, Cyclophosphamide, Axicabtagene Ciloleucel)

Recruiting
  • Lymphoma
  • Lymphoma Cns
  • Boston, Massachusetts
  • +1 more
Jan 3, 2023

Multiple Myeloma Trial in Worldwide (Cilta-cel)

Recruiting
  • Multiple Myeloma
  • Phoenix, Arizona
  • +30 more
Aug 11, 2022

Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance

Active, not recruiting
  • Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
    • Aichi, Japan
    • +48 more
    Dec 7, 2022

    Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

    Not yet recruiting
    • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
      • (no location specified)
      Dec 16, 2022

      Sickle Cell Disease Trial (Exa-cel)

      Not yet recruiting
      • Sickle Cell Disease
      • Exa-cel
      • (no location specified)
      Jul 14, 2023

      Patients With Chronic Gastrointestinal Disease

      Not yet recruiting
      • Gastrointestinal Diseases
      • Observational
      • (no location specified)
      Mar 19, 2023

      Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

      Completed
      Has Results
      • Chronic Myelogenous Leukemia
      • +3 more
      • Duarte, California
      • +100 more
      Jun 8, 2021

      Multiple Myeloma Trial (Cilta-cel OOS Therapy)

      Available
      • Multiple Myeloma
      • Cilta-cel OOS Therapy
      • (no location specified)
      Aug 15, 2022

      Non-Hodgkin Lymphoma, Large B-cell Lymphoma Trial in Palo Alto (Axicabtagene Ciloleucel)

      Not yet recruiting
      • Non-Hodgkin Lymphoma
      • Large B-cell Lymphoma
      • Axicabtagene Ciloleucel
      • Palo Alto, California
        Stanford University
      Mar 20, 2023

      Eosinophilic Colitis Trial (colonoscopy)

      Not yet recruiting
      • Eosinophilic Colitis
      • colonoscopy
      • (no location specified)
      Feb 9, 2023

      Multiple Myeloma Trial in New York (Ide-cel (bb2121))

      Recruiting
      • Multiple Myeloma
      • Ide-cel (bb2121)
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jul 6, 2022

      Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported

      Active, not recruiting
      • Diffuse Large B Cell Lymphoma
      • Transformed Lymphoma
      • Handgrip strength test
      • +9 more
      • Tampa, Florida
        Moffitt Cancer Center
      Jan 12, 2023

      Systemic Lupus Erythematosus Trial in Shanghai (Relma-cel)

      Recruiting
      • Systemic Lupus Erythematosus
      • Relma-cel
      • Shanghai, China
        Relma-cel Medical
      Mar 12, 2023

      Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)

      Not yet recruiting
      • Multiple Myeloma
      • idecabtagene vicleucel
      • +3 more
      • Gilbert, Arizona
      • +107 more
      Sep 26, 2023

      Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter Syndrome Trial

      Not yet recruiting
      • Recurrent Transformed Chronic Lymphocytic Leukemia
      • +2 more
      • Biopsy
      • +10 more
      • Duarte, California
        City of Hope Medical Center
      Jan 3, 2023

      Multiple Myeloma Trial in United States (Talquetamab)

      Recruiting
      • Multiple Myeloma
      • Basking Ridge, New Jersey
      • +6 more
      Sep 27, 2023